46 studies found for:    " January 06, 2010":" February 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 06, 2010":" February 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Conditions: HIV Infection;   HIV Infections
Intervention: Genetic: SB-728-T
2 Completed HIV Treatment and CVD Events
Conditions: HIV Infection;   Cardiovascular Disease;   Infection, Human Immunodeficiency Virus;   Acute Myocardial Infarction
Intervention: Drug: HAART Treatment
3 Unknown  Notification of Donors With Positive Microbiology Markers
Conditions: Human Immunodeficiency Virus;   Hepatitis B;   Hepatitis C;   Human T-lymphotropic Virus I & II;   Creutzfeldt-Jakob Syndrome;   HIV Infections
Intervention:
4 Completed
Has Results
Fosamprenavir in Pts With Hepatic Impairment
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Intervention A Standard dose;   Drug: Intervention B Reduced Dose;   Drug: Intervention C;   Drug: Intervention D;   Drug: Intervention E
5 Completed Preventative Misconception Intervention
Conditions: HIV;   HIV Infections
Interventions: Behavioral: 1-sided messages;   Behavioral: 2-sided messages
6 Completed Treatment for Depression Among HIV-Infected Youth
Conditions: HIV;   Depression;   HIV Infections
Interventions: Behavioral: COMB - Combination Cognitive Behavioral Therapy and Medication Management;   Behavioral: TAU - Treatment as Usual
7 Completed Cell Phone Reminders Intervention
Conditions: HAART Non-Adherence;   HIV;   HIV Infections
Intervention: Behavioral: Cell Phone Intervention
8 Withdrawn An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons
Conditions: HIV;   HIV Infections
Intervention: Drug: Valacyclovir
9 Completed Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Biological: Autologous seminal fluid with Tc-99m/In-111 radiolabels;   Other: Autologous lymphocytes labeled with In-111 in normosol vehicle with TC-99m DTPA incorporated
10 Completed A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: PF-04776548
11 Active, not recruiting Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
Condition: HIV Infections
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
12 Active, not recruiting Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
Conditions: AIDS-Related Kaposi Sarcoma;   Recurrent Kaposi Sarcoma
Interventions: Drug: Lenalidomide;   Other: Laboratory Biomarker Analysis
13 Unknown  High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
14 Terminated Pre-Exposure Prophylaxis Using TMC278LA
Condition: HIV Infections
Intervention: Drug: TMC278LA
15 Completed TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions
Condition: HIV Infections
Intervention: Drug: DRV commercial formulation/ DRV new formulation/ rtv 100mg tab
16 Active, not recruiting Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins
Condition: HIV Infections
Interventions: Biological: HIV-1 DNA plasmid vaccine;   Biological: HIV-1 recombinant Ad5 vaccine
17 Terminated Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens
Condition: HIV Infections
Interventions: Drug: Maraviroc;   Drug: placebo
18 Completed Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
Conditions: HIV Infections;   Proteinuria
Intervention: Drug: change from tenofovir to raltegravir
19 Completed
Has Results
Safety and Efficacy of Salsalate to Treat Endothelial Dysfunction in HIV-infected Adults
Conditions: HIV;   Endothelial Dysfunction;   Inflammation;   Insulin Resistance
Intervention: Drug: Salsalate
20 Enrolling by invitation Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV
Conditions: Tuberculosis;   HIV
Interventions: Dietary Supplement: Immunoxel;   Drug: Placebo;   Drug: TB drugs+ Immunoxel;   Drug: ATT+Placebo;   Drug: ATT + Placebo;   Drug: drug-resistant TB on ATT+Immunoxel;   Drug: Immunoxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years